PR
Schedule 13D filing
Postma Robert W disclosed a 10% stake in Alaunos Therapeutics, Inc. (TCRT)
Postma Robert W reported owning 10% of Alaunos Therapeutics, Inc. (TCRT) (514,691 shares) in a Schedule 13D filed Oct 15, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.